Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Total Non-Current Liabilities ₹125 Cr₹159 Cr₹179 Cr₹180 Cr₹2,860 Cr

What is the latest Total Non-Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹125 Cr based on Mar2023 Consolidated results.
Year Total Non-Current Liabilities
Mar2023₹125 Cr
Mar2022₹159 Cr
Mar2021₹179 Cr
Mar2020₹180 Cr
Mar2019₹2,860 Cr

How is Total Non-Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2023 ₹125 Cr
-21.01
Mar2022 ₹159 Cr
-11.16
Mar2021 ₹179 Cr
-0.84
Mar2020 ₹180 Cr
-93.70
Mar2019 ₹2,860 Cr -

Compare Total Non-Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹41,171.0 Cr 3.2% 16.9% 90.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,673.0 Cr -2.9% 0% 59.6% Stock Analytics
CIPLA ₹119,930.0 Cr 5.8% 6.2% 60.9% Stock Analytics
DIVIS LABORATORIES ₹109,446.0 Cr 5% 8% 25.9% Stock Analytics
ZYDUS LIFESCIENCES ₹108,261.0 Cr -2.6% 15.3% 114.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,830.6 Cr 0.9% -1.5% 32.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

3.2%

16.9%

90.5%

SENSEX

2%

2.3%

22.2%


You may also like the below Video Courses